Arcellx
Arcellx is a clinical-stage biotechnology company focused on developing engineered cell therapies for cancer and other incurable diseases. The Manager, Clinical Quality will support GCP quality oversight for phase I-III clinical studies, partnering with clinical and medical affairs to ensure the quality system is compliant with applicable regulations and supports successful trials.
Arcellx is a biopharmaceutical company developing next‑generation cell therapies for cancer and autoimmune diseases. With a proprietary technology platform, they aim to reimagine and "supercharge" cell therapy to pursue cures and improve patient outcomes. The company advances engineered cell therapy candidates through research and clinical development to address unmet medical needs. Arcellx emphasizes innovation in therapeutic design and clinical translation.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arcellx.
Gilead to buy Arcellx in nearly $8B deal
2 weeks ago
Senior Director, Clinical Quality Assurance
Artiva Biotherapeutics
GCP Specialist
Capricor Therapeutics
Associate Director Clinical Quality (Cell Therapy)
AstraZeneca
Associate Director Clinical Quality (Cell Therapy)
AstraZeneca
Clinical Research Associate (in-house)
Artiva Biotherapeutics
Senior Director, Clinical Quality Assurance
altimmune